MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-RAS and HMGA2 gene expression

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 2, 2013, Pages 131-137

  Wang, Yan Ying ^a   Ren, Tao ^b   Cai, Ying Yun ^a   He, Xiao Ye ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

95D cells; invasion and metastasis; let 7a; microRNA; Nonsmall cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; HIGH MOBILITY GROUP A2 PROTEIN; K RAS PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA; MICRORNA LET 7A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA2 PROTEIN; HUMANS; LUNG NEOPLASMS; MICRORNAS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84874745011     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1307     Document Type: Article

References (31)

1. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med 2008;359:2814.
2. Hunter KW, Crawford NP, Alsarraj J. Mechanisms of metastasis. Breast Cancer Res 2008;10 (Suppl 1):S2.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10.
4. Berhoune M, Banu E, Scotte F, et al. Therapeutic strategy for treatment of metastatic non-small cell lung cancer. Ann Pharmacother 2008;42:1640.
5. Tsuruo T, Fujita N. Platelet aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser B Phys Biol Sci 2008;84:189.
6. Ortholan C, Puissequr MP, Ilie M, et al. MicroRNAs and lung cancer: New oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem 2009;16:1047.
7. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775.
8. Hammond S. MicroRNAs as tumor suppressors. Nat Genet 2007;39:582.
9. Croce CM. Oncogenes and cancer. N Engl J Med 2008; 358:502.
10. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:535.
11. Kumar MS, Erkeland SJ, Pester RE, et al. Suppression of nonsmall cell lung tumor development by the let-7a microRNA family. Proc Natl Acad Sci USA 2008;105:3903.
12. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753.
13. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189.
14. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007;21:1025.
15. Ren T, He XY, Cai YY, et al. TLR9 agonist enhances lung cancer invasiveness by alternating miRNA expression profile. Sci Res Essays 2011;6:2519.
16. Gao W, Shu YQ. The progress of microRNA application in non-small cell lung cancer. Chin J Exp Surg 2009;26:270.
17. Esquela-Kerscher A, Trang P, Wiggins JF, et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008;7:759.
18. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007;315:1576.
19. Park SM, Shell S, Radjabi AR, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007;6:2585.
20. Sarhadi VK, Wikman H, Salmenkivi K, et al. Increased expression of high mobility group A proteins in lung cancer. J Pathol 2006;209:206.
21. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol 2007;17:118.
22. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 2008;9:102.
23. Eulalio A, Behm-Ansmant I, Izaurralde E. P bodies: At the crossroads of post-transcriptional pathway. Nat Rev Mol Cell Biol 2007;8:9.
24. de Sousa Abreu R, Penalva LO, Marcotte EM, et al. Global signatures of protein and mRNA expression level. Mol Biosyst 2009;5:1512.
25. Ostlund G, Sonnhammer EL. Quality criteria for finding genes with high mRNA-protein expression correlation and coexpression correlation. Gene 2012;497:228.
26. Greenbaum D, Colangelo C, Williams K, et al. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003;4:117.
27. Beyer A, Hollunder J, Nasheuer HP, et al. Post-transcriptional expression regulation in the yeast Saccharomyces cerevisiae on a genomic scale. Mol Cell Proteomics 2004;3:1083.
28. Nie L, Wu G, Zhang W. Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: A quantitative analysis. Genetics 2006;174:2229.
29. Trang P, Wiggins JF, Daige CL, et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 2011; 19:1116.
30. Wu Y, Crawford M, Yu B, et al. MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol Pharm 2011;8:1381.
31. Lu Y, Govindan R, Wang L, et al. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 2012;33:1046.